Poor Control of Cardiovascular Risk Factors Common in Men With Prostate Cancer
An analysis of data from the RADICAL-PC study sought to determine the link between prostate cancer and risk factors for cardiovascular disease.
An analysis of data from the RADICAL-PC study sought to determine the link between prostate cancer and risk factors for cardiovascular disease.
Researchers sought to determine CV event occurrence in patients treated with immune checkpoint inhibitors and assess the accuracy of diagnosis by ICD code compared with adjudication using established definitions.
Statin use in prostate cancer is attractive given their proven cardiovascular benefits and favorable toxicity profile, according to investigators.
Odds are disproportionately increased with annual household income <$50,000; are reduced with performance of MVPA.
Researchers investigated the risk of cardiovascular events in patients with MPN and atrial fibrillation, and evaluated the predictive value of traditional risk scores.
A study of the literature explored the potential of carotid IMT to predict risk of coronary artery disease in patients undergoing radiotherapy for HNC.
Researchers sought to determine risk predictors for coronary heart disease and heart failure in Hodgkin lymphoma survivors who were aged 18 to 50 at diagnosis.
Among patients with cHL, mortality risk related to cancer has declined, but CVD mortality risk has decreased slowly or remained stable.
In stratified analysis, odds of all-cause mortality, hospital stay of more than five days higher for MM patients not using anticoagulation.
A review of the results of the Pathways Heart Study, which sought to identify the link between a history of breast cancer treatment and cardiovascular risks in women.